Clinical Trial Update: 68Gallium-FAPI46 PET/CT Imaging in Chronic Inflammatory and Fibrotic Diseases [NA]

View source ↗

Summary

This clinical trial update reports ongoing recruitment for a study evaluating 68Ga-FAPI46 PET/CT imaging in chronic inflammatory and fibrotic diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrosis
• Inflammatory Disease

Drugs mentioned

• 68Ga-FAPI46 (Gallium-68 labeled fibroblast activation protein inhibitor (FAPI-46) radiotracer)

Snippet

Sponsor: University Hospital, Brest | Conditions: Inflammatory Disease | NA | Status: RECRUITING